Rating History for ANI Pharmaceuticals (ANIP) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/9/2026 | Daniel Clark | New Coverage | Outperform (N/A) |
104.00 (N/A) |
70.23 (72.29) |
2.93% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/9/2026 | Daniel Clark | New Coverage | Outperform (N/A) |
104.00 (N/A) |
70.23 (72.29) |
2.93% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||